Abstract
The selectivity of Helicobacter pylori for the antral mucosa of the stomach and gastric metaplasia in the duodenum combined with the inaccessibility of those sites has hindered the investigation of this infection. Consequently, the study of the epidemiology and treatment of H. pylori has relied heavily on indirect methods of detecting infection. Therefore, the accuracy of findings from such studies, particularly those with small populations, was highly dependent on the sensitivity and specificity of the detection systems employed. The calculation of sensitivity, specificity, and positive and negative values of a test requires a “gold standard.”. The choice of gold standard, against which to validate the test, is important as it will have its own margins of error. Ideally, the gold standard and its margins of error should be identified when quoting sensitivity and specificity rates in validation of any new diagnostic test. For example, if a test has a sensitivity of 95% against a gold standard that has a true sensitivity of 85%, then the true sensitivity of the first test for its target would be 0.95 × 0.85 = 0.8, i.e., 80 and not 95%. In the case of H. pylori, the most commonly used gold standard in early work on indirect diagnostic methods was culture and/or histology. These two methods possibly have relatively the lowest sensitivity of any test for the presence of H. pylori. This is owing to the potential sampling error in removing biopsy material from an uninfected site. This, combined with variable culture efficiency and identification in histological sections, will lead to false negatives (1). This would be a particular problem in patients with any changes to the gastric mucosal epithelium from typical antral epithelium, such as intestinal metaplasia, because the changes would remove the niche availability to H. pylori and reduce the infective load.The problems can be minimized, for example, by staining histological sections with the modified Giemsa stain, making the recognition of H. pylori easier, even when the organism is present in small numbers. The combination of culture and histology is preferable to using either of the two independently, and certainly preferable to using endoscopic appearance alone, to estimate the sensitivity and specificity of a test. Many workers only count a case as H. pylori positive when two out of three indirect tests are positive.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Glupczynski, Y. (1994) The diagnosis of Helicobacter pylori infection a microbiologist’s perspective. Rev. Med. Microbiol. 5, 199–208.
Logan, R., Dill, S., Walker, M., Bauer, F., Gummet, P A., Hirschl, A, Rathbone, B., Johnson, P, Baron, J H., and Misiewicz, J. J (1990) The detection of H pylori using a European standard 13Carbon urea breath test. Rev Esp Enfermedades Digestivas 78(Suppl.1), 14.
Trautmann, M., Moldryzk, M., Vogt, K., Held, T., and Marre, R. (1994) Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur. J Clin Microbiol Infect Dis 13, 812–819.
Stacey, A R., Hawtin, P. R., and Newell, D. G. (1990) Antigenicity of fractions of Helicobacter pylori prepared by fast protein liquid chromatography and urease captured by monoclonal antibodies.Eur J Clin. Microbiol. Infect. Dis 9, 732–737.
Cover, T L, Glupczynski, Y., Lage, A.P., Burette, A., Tummuru, M. K. R., Perez-Perez, G. I., and Blaser, M. J. (1995) Serologic detection of infection with cagA + Helicobacter pylori strains. J. Clin. Microbiol 33, 1496–1500.
The Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341, 1359–1362.
Newell, D. G., Johnston, B. J, Ali, M. H., and Reed, P. I (1988) an enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori associated gastritis. Scan J. Gastroenterol. 23Suppl. 142), 53–57
Booth, L., Holdstock, G., MacBride, H., Hawtin, P., Gibson, J, Ireland, A, Bamforth, J., DuBoulay, C. E., Lloyd, R. S., and Pearson, A. D. (1986) Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy J Clin Pathol. 39, 215–219.
Evans, D J., Evans, D. G., Graham, D. Y, and Klein, P. D (1989) A sensitive and specific serologic test for the detection of Campylobacter pylori infection. Gastroenterology 96, 1004–1008.
Hawtin, P. R., Stacey, A. R, and Newell, D. G (1990) Investigation of the structure and localisation of the urease of Helicobacter pylori using monoclonal antibodies. J Gen. Microbiol 136, 1995–2000.
Graham, D. Y., Klein, P. D., Evans, D. J., Graham, D Y., Klein, P D., Evans, D. J, Alpert, L. C., Opekum, A. R., and Boutton, T W. (1987) Campylobacter pylori detected non-invasively by the 13C-urea breath test Lancet 1, 1443–1444
Bell, G. D, Weil, J., Harrison, G., Bell, G. D., Weil, J, Harrison, G., Morden, A, Jones, P. H., Gant, P. W., Trowell, J. E., Young, A. K., Daneshmend, T. K, and Logan, R. F. (1987) 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet, 1, 1367,1368.
Weil, J., Bell, G.D., Powell, K., Weil, J, Bell, G. D., Powell, K., Morden, A., Harrison, G., Gant, P W., Jones, P. H, and Trowell, J. E (1991) Omeprazole and Helicobacter pylori temporary suppression rather than true eradication. Aliment. Pharmacol Therap 5, 303–313.
Weil, J.and Bell, G D. (1989) Detection of Campylobacter pylori by the t4C-breath test, in: Campylobacter pylori and Gastroduodenal disease (Rathbone, B. J. and Heatley, V R., eds.), Blackwell Scientific, Oxford, pp. 74–87.
Steer, H.W., Hawtin, P. R., and Newell, D. G. (1987) An ELISA technique for the serodiagnosis of Campylobacter pyloridis infection in patients with gastritis and benign duodenal ulceration. Serodiagnosis Immunother 1, 253–259.
von Wulffen, H. (1992) An assessment of serological tests for the detection of Helicobacter pylori. Eur J Clin. Microbiol Infect Dis 11, 577–582
Rauws, E. A. J., Royen, E. A. V., Langenberg, W., Rauws, E. A. J., Royen, E. A. V., Langenberg, W., Woensel, J. V., Vrij, A. A., and Tytgat, G. N. (1989) t4C-urea breath test in C. pylori gastritis. Gut 30, 798–803
Bell, G D. (1993) Urea breath tests, in Helicobacter pylori infection (Northfield, T. C., Mendall, M., and Goggin, P. M., eds.), Kluwer Academic, Dordrecht, pp 127–138.
Logan, R. P. H. (1992) Detection of Helicobacter pylori by the 13C-urea breath test, in Helicobacter pylori and Gastroduodenal Disease (Rathbone, B J and Heatley, R. V., eds), Blackwell Scientific, Oxford, pp 88–106.
Stubbs, J. B. and Marshall, B. J. (1993) Radiation dose estimates for the carbon 14-labelled urea breath test. J Nucl Med 34, 821–825
Gerstenecker, B., Eschweiler, B., Vogele, H., Koch, H. K., Hellerich, U., and Kist, M (1992) Serodiagnosis of Helicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. Eur J Clin. Microbiol Infect Dis 11, 595–601.
Wilcox, M.H., Dent, T H S., Hunter, J. O., Gray, J. J, Brown, D. F J., Wight, D G. D., and Wraight, E P (1996) Accuracy of serology for the diagnosis of Helicobacter pylori Infection—a comparison of eight kits J Clin Pathol 49, 373–376.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hawtin, P.R. (1997). Serology and Urea Breath Test in the Diagnosis of H. pylori Infection. In: Clayton, C.L., Mobley, H.L.T. (eds) Helicobacter pylori Protocols. Methods in Molecular Medicine, vol 8. Humana Press. https://doi.org/10.1385/0-89603-381-3:19
Download citation
DOI: https://doi.org/10.1385/0-89603-381-3:19
Publisher Name: Humana Press
Print ISBN: 978-0-89603-381-8
Online ISBN: 978-1-59259-592-1
eBook Packages: Springer Protocols